🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this prospective single-centre phase II study is to investigate ...
Status
Completed
Location
KH Rudolfstiftung
Start Date
2006-10
Trial ID
NCT01216345
Treatments Being Tested
A phase II trial evaluating intra-hepatic chemotherapy with oxaliplatin eve...
Status
Completed
Location
Herlev Hospital
Start Date
2011-02-02
Trial ID
NCT01247337
The primary objective is to investigate the objective response rate in pati...
Status
Completed
Location
National Institute of Cancer Research, Taiwan Cooperative Oncology Group
Start Date
2010-12
Trial ID
NCT01267344
Treatments Being Tested
The purpose of this study is to learn about the safety and effects of the s...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2024-12-10
Trial ID
NCT06704724
The study is a first-in-human (FIH), open-label, multi-center phase 1/2 stu...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-04-29
Trial ID
NCT06385925
The main purpose of this study is to assess safety \& tolerability and anti...
Status
Recruiting
Location
City of Hope
Start Date
2024-09-12
Trial ID
NCT06586515
Treatments Being Tested
During this open label study patients will receive IMM-101 in conjunction w...
Status
Terminated
Location
Centre Léon Bérard, Dpt Medecine & INSERM
Start Date
2017-05-31
Trial ID
NCT03009058
This study is being done to answer the following question: Is the combinat...
Status
Unknown
Location
Virginia mason medical Center
Start Date
2020-11-25
Trial ID
NCT04668976
The purpose of this study is to learn about the safety and effects of the s...
Status
Active Not Recruiting
Location
Highlands Oncology Group, PA
Start Date
2024-06-27
Trial ID
NCT06447662
RATIONALE: Monoclonal antibodies, such as cetuximab, can block tumor growth...
Status
Completed
Location
University of Miami Sylvester Comprehensive Cancer Center - Miami
Start Date
2006-05
Trial ID
NCT00448838
Treatments Being Tested